Progression breast anticancer drugs or radiation. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy12

Breast Cell Line, Tumor Tumor Cells, Cultured MCF-7 Cells Cell Line Cells, Cultured HeLa Cells Mammary Glands, Human HCT116 Cells HT29 Cells Fibroblasts Neoplastic Stem Cells

Organisms5

Mice, Nude Mice, Inbred BALB C Mice, SCID Mice, Inbred C57BL Mice, Transgenic

Diseases42

Disease Progression Radiation Injuries Carcinoma, Ductal, Breast Breast Diseases Neoplasms Neoplasm Metastasis Neoplasm Invasiveness Breast Neoplasms, Male Radiation Injuries, Experimental Neoplasms, Radiation-Induced Radiation Pneumonitis Breast Neoplasms Fibrocystic Breast Disease Carcinoma Adenocarcinoma Mammary Neoplasms, Experimental Lung Neoplasms Carcinoma, Intraductal, Noninfiltrating Cell Transformation, Neoplastic Colonic Neoplasms Neoplasm Recurrence, Local Brain Neoplasms Prostatic Neoplasms Lymphatic Metastasis Ovarian Neoplasms Neovascularization, Pathologic Disease Models, Animal Carcinoma, Lobular Neoplasms, Experimental Acute Radiation Syndrome Melanoma Carcinoma, Squamous Cell Bone Neoplasms Neoplasms, Hormone-Dependent Liver Neoplasms Radiodermatitis Genetic Predisposition to Disease Head and Neck Neoplasms Glioblastoma Carcinoma in Situ Glioma Skin Neoplasms

Chemicals and Drugs72

Antineoplastic Agents Doxorubicin Antineoplastic Agents, Phytogenic Antibiotics, Antineoplastic Cisplatin Receptors, Estrogen Tumor Markers, Biological Neoplasm Proteins Receptor, erbB-2 Drug Carriers Radiation-Sensitizing Agents RNA, Messenger Tumor Suppressor Protein p53 Tamoxifen Ellipticines Camptothecin Etoposide Fluorouracil Paclitaxel Receptors, Progesterone P-Glycoprotein Enzyme Inhibitors RNA, Small Interfering DNA, Neoplasm Cell Cycle Proteins DNA-Binding Proteins DNA Topoisomerases, Type II DNA Radiation-Protective Agents Proto-Oncogene Proteins c-bcl-2 Prodrugs Protein-Serine-Threonine Kinases Antineoplastic Agents, Hormonal Antimetabolites, Antineoplastic Plant Extracts Tumor Suppressor Proteins Taxoids Caspases Topoisomerase I Inhibitors Antibodies, Monoclonal Anticarcinogenic Agents Caspase 3 Antineoplastic Agents, Alkylating Daunorubicin Mitoxantrone Organoplatinum Compounds Platinum Vinblastine Nuclear Proteins Cyclophosphamide Nanocapsules Transcription Factors Cobalt Radioisotopes Mitomycin ATP-Binding Cassette Transporters Protein Kinase Inhibitors DNA Adducts Receptor, Epidermal Growth Factor Antibodies, Monoclonal, Humanized Estrogens Deoxycytidine Proto-Oncogene Proteins c-akt Proto-Oncogene Proteins Estrogen Receptor alpha Methotrexate Reactive Oxygen Species Multidrug Resistance-Associated Proteins Angiogenesis Inhibitors RNA, Neoplasm Cyclin-Dependent Kinase Inhibitor p21 Bleomycin Drugs, Investigational

Analytical, Diagnostic and Therapeutic Techniques and Equipment70

Radiation Dosage Dose-Response Relationship, Radiation Drug Screening Assays, Antitumor Radiation Monitoring Xenograft Model Antitumor Assays Drug Delivery Systems Prognosis Radiation Injuries, Experimental Radiotherapy Immunohistochemistry Treatment Outcome Drug Carriers Mammography Antineoplastic Combined Chemotherapy Protocols Neoplasm Staging Blotting, Western Neoplasm Transplantation Radiotherapy Dosage Combined Modality Therapy Risk Factors Breast Implants Inhibitory Concentration 50 Radiometry Reverse Transcriptase Polymerase Chain Reaction Follow-Up Studies Survival Analysis Transplantation, Heterologous Gene Expression Profiling Breast Self-Examination Models, Biological Mammary Neoplasms, Experimental Mastectomy Drug Design Disease-Free Survival Tumor Burden Retrospective Studies Transfection Case-Control Studies Molecular Targeted Therapy Survival Rate Disease Models, Animal Chemotherapy, Adjuvant Radiotherapy, Adjuvant Prospective Studies Neoplasms, Experimental Flow Cytometry Clinical Trials as Topic Drug Evaluation, Preclinical Cohort Studies Mastectomy, Segmental Oligonucleotide Array Sequence Analysis Ultrasonography, Mammary Radiotherapy, Conformal Drug Discovery Sensitivity and Specificity Reproducibility of Results Nanocapsules Dose Fractionation Risk Assessment Mammaplasty Tumor Stem Cell Assay Brachytherapy Drug Administration Schedule Radiation Hybrid Mapping Gene Knockdown Techniques Radiotherapy, Intensity-Modulated Predictive Value of Tests Kaplan-Meier Estimate Polymerase Chain Reaction Incidence

Psychiatry and Psychology2

Breast Feeding Breast Self-Examination

Phenomena and Processes55

Radiation Dosage Radiation, Ionizing Dose-Response Relationship, Radiation Radiation Tolerance Radiation Apoptosis Drug Resistance, Neoplasm Gene Expression Regulation, Neoplastic Cell Proliferation Breast Feeding Cell Cycle Cell Survival Time Factors DNA Damage Gamma Rays Signal Transduction Cosmic Radiation Dose-Response Relationship, Drug Cell Division Background Radiation Ultraviolet Rays Inhibitory Concentration 50 Drug Resistance, Multiple Mutation Drug Synergism Molecular Structure Down-Regulation DNA Repair Radiation Effects Transfection Phosphorylation Base Sequence Up-Regulation Gene Expression Cell Death Cell Movement RNA Interference G2 Phase X-Rays Phenotype Cell Cycle Checkpoints Genes, BRCA1 Sensitivity and Specificity Enzyme Activation G1 Phase Promoter Regions, Genetic S Phase Mitosis DNA Adducts Postmenopause Protein Binding Genes, p53 Structure-Activity Relationship Drug Resistance Genetic Predisposition to Disease

Disciplines and Occupations6

Radiation Oncology Immunohistochemistry Drug Design Nanomedicine Drug Discovery Radiobiology

Technology, Industry, Agriculture3

Nanoparticles Nanomedicine Nanocapsules

Information Science6

Molecular Sequence Data Base Sequence Survival Rate Radiotherapy, Conformal Radiotherapy, Intensity-Modulated Incidence

Health Care29

Radiation Dosage Radiation Injuries Dose-Response Relationship, Radiation Radiation Protection Radiation Monitoring Cosmic Radiation Radiation Injuries, Experimental Treatment Outcome Ultraviolet Rays Risk Factors Follow-Up Studies Survival Analysis Disease-Free Survival Radiation Effects Retrospective Studies Case-Control Studies Survival Rate Prospective Studies Clinical Trials as Topic Cohort Studies Acute Radiation Syndrome Sensitivity and Specificity Reproducibility of Results Risk Assessment Radioactive Hazard Release Predictive Value of Tests Kaplan-Meier Estimate Age Factors Incidence

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Technology, Industry, Agriculture Information Science Health Care

Breast Disease Progression Antineoplastic Agents Radiation Dosage Radiation, Ionizing Cell Line, Tumor Radiation Injuries Carcinoma, Ductal, Breast Dose-Response Relationship, Radiation Radiation Tolerance Breast Diseases Neoplasms Radiation Drug Screening Assays, Antitumor Radiation Protection Radiation Monitoring Apoptosis Drug Resistance, Neoplasm Tumor Cells, Cultured Gene Expression Regulation, Neoplastic Cell Proliferation Doxorubicin Antineoplastic Agents, Phytogenic Breast Feeding Mice, Nude Cell Cycle Cell Survival Antibiotics, Antineoplastic Radiation Oncology Cisplatin Time Factors Xenograft Model Antitumor Assays Drug Delivery Systems DNA Damage Prognosis Receptors, Estrogen Neoplasm Metastasis Gamma Rays Signal Transduction Tumor Markers, Biological Cosmic Radiation Neoplasm Proteins Neoplasm Invasiveness Breast Neoplasms, Male Radiation Injuries, Experimental Radiotherapy Neoplasms, Radiation-Induced Immunohistochemistry Treatment Outcome Receptor, erbB-2 Dose-Response Relationship, Drug Drug Carriers Radiation Pneumonitis Mammography Antineoplastic Combined Chemotherapy Protocols Cell Division Breast Neoplasms Radiation-Sensitizing Agents RNA, Messenger Tumor Suppressor Protein p53 Neoplasm Staging Tamoxifen Blotting, Western Fibrocystic Breast Disease MCF-7 Cells Ellipticines Neoplasm Transplantation Background Radiation Ultraviolet Rays Radiotherapy Dosage Camptothecin Etoposide Combined Modality Therapy Fluorouracil Paclitaxel Carcinoma Adenocarcinoma Risk Factors Breast Implants Receptors, Progesterone Inhibitory Concentration 50 P-Glycoprotein Radiometry Drug Resistance, Multiple Mutation Reverse Transcriptase Polymerase Chain Reaction Drug Synergism Follow-Up Studies Enzyme Inhibitors RNA, Small Interfering Survival Analysis Transplantation, Heterologous Molecular Structure Gene Expression Profiling Breast Self-Examination Models, Biological Mammary Neoplasms, Experimental Lung Neoplasms Down-Regulation Carcinoma, Intraductal, Noninfiltrating

No FAQ available that match "progression breast anticancer drugs or radiation"